Hair loss had been reported in weight-management trials and post-marketing data, but important questions remained unanswered: Is the medication itself responsible
They also identified some secondary benefits, such as lowering cholesterol
A 2022 warning letter from the Office of Prescription Drug Promotion (OPDP) highlighted an Instagram ad posted by the company that reportedly made, false or misleading claims and representations about the benefits and risks of Trulicity. It found that the company minimized the risks and overemphasized the benefits of the drug
A year later Thorens published a second paper together with collaborators in Lausanne reporting on the cloning, sequencing and functional expression of the human GLP-1 receptor (Thorens, Porret, Bhler)
Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of medications primarily used to manage type 2 diabetes and, in some formulations, to support weight management
And were actually tapering her medications down , not adding more
